Zeto
Zeto is a privately held medical technology company that sells FDA-cleared wireless dry-electrode EEG headsets and a HIPAA-compliant cloud platform to hospitals, neurology practices, and clinical research sites, supplemented by AI-powered seizure detection and reporting tools.
- Company typePrivate
- Founded2019
- HeadquartersSanta Clara, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Zeto does
Zeto, Inc. is a privately held medical technology company that develops wireless, dry-electrode EEG headsets and a HIPAA-compliant cloud platform for hospitals, outpatient neurology practices, and clinical research sites. The company's core technology pairs proprietary active dry-electrode hardware with signal pre-amplification at the scalp (CMRR above 130dB) and a cloud platform that supports remote viewing, multi-site multi-user data management, and AI-powered seizure detection. Its product portfolio comprises the Zeto ONE headset for critical care settings (ICU, emergency departments, EMS) and the New Wave headset for outpatient and home use, both delivering full 10-20 montage coverage with average setup times under five minutes versus 20-40 minutes for conventional EEG systems.
The company generates revenue through direct enterprise sales of FDA-cleared hardware combined with subscription-based cloud platform access, AI seizure detection (NeuroPulse), and AI-assisted EEG reporting (NeuroNotis), with optional board-certified neurologist interpretation services as an add-on. Its go-to-market motion is enterprise field sales targeting hospital systems, neurology practices, and academic medical centers, supported by a clinical trial sponsorship program running annually across the US, UK, and Australia that builds clinical evidence and institutional relationships. The customer base spans solo neurology practices, mid-market multispecialty clinics, and enterprise health systems including UPMC Children's Hospital of Pittsburgh, Huntsville Memorial Hospital, Ukiah Adventist Hospital, and MD Anderson, with 200+ US healthcare facilities using the platform.
Zeto has secured three FDA 510(k) clearances and built its AI capability through a partnership with encevis (Austrian Institute of Technology), whose seizure detection model is trained on more than 21,400 hours of EEG data from 800+ patients. The company is backed by venture capital with cumulative disclosed funding of approximately $54 million, anchored by a $31 million Series B in January 2025 led by MindWorks Capital. Leadership includes founder and CEO Aswin Gunasekar, CTO Gabor Braun, CFO Neway Redia, and Chief Sales Officer Florian Strelzyk. Active research collaborations extend across multiple US institutions (Vanderbilt, UT Austin, Baylor, UNC, VA Charleston) and into underserved markets including Nigeria and Zambia.
Zeto firmographics
Firmographics- Name
- Zeto
- Legal name
- Zeto, Inc.
- Website
- https://zeto-inc.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Zeto is a privately held medical technology company that sells FDA-cleared wireless dry-electrode EEG headsets and a HIPAA-compliant cloud platform to hospitals, neurology practices, and clinical research sites, supplemented by AI-powered seizure detection and reporting tools.
- Ownership category
- akta.pro rank
Zeto industry classification
Industry- Product category
- Neurology Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industry
- Epilepsy & Seizure Disorders (HLAKAIAB)
Keywords
Where Zeto is headquartered
LocationHeadquarters
- HQ city
- Santa Clara
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Zeto business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Hardware Sales - EEG Headsets: Sale of FDA-cleared EEG hardware devices including Zeto ONE and New Wave headsets to healthcare facilities, hospitals, and outpatient clinics.
- Cloud Platform Subscription: Cloud-based EEG data access, storage, and analysis platform provided as part of service agreements. Includes remote viewing, video EEG, and data management capabilities.
- AI-Powered Software Analysis: NeuroPulse seizure detection and NeuroNotis AI-enabled reporting services provided as add-on capabilities within existing service agreements.
- EEG Reading Services: Optional EEG interpretation services by board-certified neurologists available as an add-on service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Zeto ONE - For Critical Care/ICU Settings |
| Subscription | Annual | New Wave - For Outpatient EEG |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
Zeto product offering
Product offeringCore offering
Zeto designs and sells FDA-cleared wireless, gel-free, dry-electrode EEG headsets (Zeto ONE for ICU/ED/EMS and New Wave for outpatient and home use) and delivers the recordings through a HIPAA-compliant cloud platform that includes live video EEG viewing and AI-powered seizure detection. The company also offers NeuroNotis AI-enabled reporting reviewed by Stratus Registered EEG Technologists and optional EEG interpretation services by board-certified neurologists.
Differentiator
Problem solved
Functional benefit
Brands
- Zeto ONE: Second-generation EEG system designed for critical care settings including ICU, emergency departments, and EMS vehicles with extended recording capabilities.
- New Wave
- NeuroPulse
- NeuroNotis
Products and services
- Zeto ONE EEG Headset FDA-cleared wireless EEG headset for critical care settings (ICU, ED, EMS), providing full 10-20 montage EEG with extended recording capability, gel-free dry electrodes, sub-5-minute setup, and cloud-based remote viewing for hospitals and emergency services.
- New Wave EEG Headset FDA-cleared compact outpatient EEG system for neurology practices, clinics, and home-based care, supporting routine EEG studies up to 2.5 hours with 21 dry electrodes, technician-free application, and remote access through the Zeto cloud platform.
- NeuroPulse AI Seizure Detection AI-powered seizure burden and Status Epilepticus detection capability that analyzes full 10-20 EEG recordings in real time to alert clinicians of seizure activity in critical care, emergency, and outpatient settings.
- NeuroNotis Report AI-enabled EEG report service that combines automated seizure detection with human review by Stratus Registered EEG Technologists, producing a clinical report approximately 15 minutes after the first hour of recording for hospitals and neurology practices.
- Zeto Cloud Platform HIPAA-compliant cloud platform that delivers remote access to live video EEG, multi-site multi-user collaboration, data management, archiving, and integrates AI seizure detection and reporting for Zeto hardware customers.
Quantifiable outcome
- Setup time reduced from 20-40 minutes to under 5 minutes
- +5 more outcomes
Companies that use Zeto
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
Zeto technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature7 records
Zeto partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Stratus Registered EEG TechnologistscoreHuman review partnership for NeuroNotis AI-enabled EEG reports. Stratus R. EEG T. provides technical review of AI-generated reports to address clinical decision-making uncertainty when relying solely on AI algorithms. Results delivered approximately 15 minutes after first hour of recording at no additional cost within existing service agreements.
- MD Anderson Cancer Center - Neurology DepartmentminorResearch collaboration on brain-computer interface project connecting EEG technology with music therapy. Dr. Mei Rui at MD Anderson encouraged expansion of the system to detect and map multiple brain regions and frequency bandwidths to musical motifs for therapeutic purposes.
- encevis (Austrian Institute of Technology)coreCollaboration to integrate NeuroPulse AI-powered seizure burden and Status Epilepticus detection capability into Zeto's full 10-20 EEG platform. The encevis AI model was trained on over 21,400 hours of EEG recordings from more than 800 patients and validated on an independent dataset of 81 patients. This addresses critical unmet need as up to one-third of neurological critical care and emergency department patients are at risk for seizures.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Zeto competitors and assessment
Company assessmentDirect peers
- Natus Medical: One of the largest legacy EEG hardware and neurology diagnostics vendors globally. Directly competes with Zeto across hospital EEG, ICU monitoring, and outpatient neurology workflows, with established reimbursement and procurement relationships that Zeto is working to displace.
- Compumedics: Australia-based EEG and sleep diagnostics company offering hospital-grade EEG systems, ambulatory EEG, and cloud review platforms. Competes head-on with Zeto's hardware-plus-cloud strategy in neurology and ICU/critical-care EEG.
- Cadwell Industries: US-based neurodiagnostic equipment maker with a long-standing hospital and outpatient EEG installed base. Competes directly with Zeto in routine and ambulatory EEG, with comparable clinical customer segments.
- Wave Neuroscience: EEG-focused company developing clinical and consumer EEG platforms, including qEEG/MEG-adjacent offerings. Competes with Zeto at the intersection of clinical EEG hardware, AI analytics, and neurotechnology applications.
- Brain Products: Germany-based maker of research- and clinical-grade EEG systems widely used in academic and clinical research settings. Competes with Zeto in the clinical-research segment Zeto targets via its sponsorship program and academic medical center sales.
- ANT Neuro: Netherlands-based EEG and neuromodulation company with hospital and research-oriented EEG products. Comparable to Zeto in its mix of clinical and research customers and its focus on full-montage EEG systems.
Emerging players
- Emotiv: Consumer and prosumer EEG headset maker with growing developer/research presence. Adjacent to Zeto via dry-electrode EEG hardware, though Emotiv primarily targets B2C, B2B research, and brain-computer-interface use cases rather than FDA-cleared clinical workflows.
- Cumulus Neuroscience: Clinical-stage EEG platform company focused on at-home EEG assessments for CNS clinical trials. Comparable to Zeto in applying EEG to clinical research and outpatient use cases, with overlapping neurology and CNS trial customers.
Broad incumbents
- Ceribell: Point-of-care EEG company focused on ICU seizure detection with an FDA-cleared rapid-EEG headset and cloud platform. Directly competes with Zeto ONE in the same ICU and ED use case and has raised significantly more capital at a much larger scale.
- iRhythm Technologies: Public ambulatory cardiac monitoring company with an AI-enabled wearable + cloud platform business model. Comparable to Zeto in its mix of FDA-cleared hardware, AI diagnostic algorithms, and recurring service revenue per patient test.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Zeto social profiles
Digital presenceZeto compliance and trust
Trust signalCompliance1 record
Zeto financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zeto leadership team
Management profileNumber of profiles
Profiles4 records
Zeto funding detail
Funding detailFunding overview
Funding rounds7 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zeto M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zeto
What does Zeto do?
Zeto designs and sells FDA-cleared wireless, gel-free, dry-electrode EEG headsets (Zeto ONE for ICU/ED/EMS and New Wave for outpatient and home use) and delivers the recordings through a HIPAA-compliant cloud platform that includes live video EEG viewing and AI-powered seizure detection. The company also offers NeuroNotis AI-enabled reporting reviewed by Stratus Registered EEG Technologists and optional EEG interpretation services by board-certified neurologists.
Is Zeto a public or private company?
Zeto is a private company. It is classified as venture growth investor backed and is currently operating.
When was Zeto founded?
Zeto was founded in 2019. It employs 11 to 50 people.
Where is Zeto based?
Zeto is headquartered in Santa Clara, United States, in the North America region.
How does Zeto make money?
Four revenue lines are on record. Hardware Sales - EEG Headsets are the primary driver. The others are cloud Platform Subscription, AI-Powered Software Analysis and EEG Reading Services.
Who are Zeto's main competitors?
Direct peers on record are Natus Medical, Compumedics, Cadwell Industries, Wave Neuroscience, Brain Products and ANT Neuro. Emerging players are Emotiv and Cumulus Neuroscience. Broad incumbents are Ceribell and iRhythm Technologies.
Does Zeto have an API?
No public API is recorded for Zeto.
What industry is Zeto in?
Zeto's product category is Neurology Diagnostic Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAB, Epilepsy & Seizure Disorders. Its NAICS code is 334510 and its SIC code is 3845.